Biboys sold for near $50 million to ATI, then it was sold to Qualcomm.
This is how most semiconductor startups work. Do better and show innovation that is bought buy bigger players.
This is how most semiconductor startups work. Do better and show innovation that is bought buy bigger players.
Thus, in hardware, funding comes from the existing players who already know the hardware business with its cyclic business and other associated risks.
One (A SINGLE) photolithography machine is like $4B.
There’s no way for a new player to enter the CPU market
Most likely you'd be supplying an "IP core", which is basically just software. More niche than that, if you actually wanted to supply physical chips, you would contract out the manufacturing to TSMC for example.
I think there's two problems with hardware: first the marginal profit per unit doesn't scale so to make more profit you have to sell more widgets. The same is mostly true for biotech but the profit margins on a drug are usually >95%, with a much higher ceiling, and are heavily recurring, often for the life of a patient. Since biotech customers are mostly insurance companies, the value of a drug is easy to calculate based on its quality of life improvements and past deals.
Second, success is very all or nothing for hardware companies. Each hardware startup will have a limited number of possible acquirers who specialize in their field so they either become profitable and go public or fail. On the other hand, failed tech companies get acquihired by the tech giants and pharmaceutical companies acquire tons of companies before they even finish clinical trials. Any startup that makes it past phase 3 trials has a 99% chance of getting acquired by a pharmaceutical company so the economics of investing are very enticing, despite the massive capital outlays.